Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acidosis correction" refers to the set of medical and physiological interventions applied to restore normal blood pH when a patient is experiencing acidosis, such as metabolic or respiratory acidosis. This is accomplished not by targeting a discrete molecule or receptor, but rather by correcting the underlying cause—such as administering intravenous fluids, sodium bicarbonate, or treating the precipitating illness (e.g., diabetic ketoacidosis, kidney failure, poisoning, etc.)[1][2][3][5]. Physiological compensation can involve increased respiratory rate to expel CO₂ or renal adjustments to increase acid excretion and/or bicarbonate retention[2][6]. There is no unique molecular target called "Acidosis correction," and this term should not be used as a target in therapeutic databases or structured drug-target resources. The intervention involves system-level regulation and multiple organ responses, rather than a single, targetable molecule or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acidosis correction.